In the case of the GSE23743 dataset, four Ph+ ALL cell lines (BV-173, NALM-1, SUP-B15, and TOM1) were either treated with 10μM STI571 (Imatinib) for 16 h or cultured in absence of STI571 (treated n = 4, untreated n = 4). Here, TOM1 is linked to acute lymphoblastic leukemia.